We show that single agent ATR inhibition is more sensitive in tumours with higher cell cycle gene expression and an increased frequency of DDR mutations, as well as more sensitive in MGMT unmethylated and TMZ+RT resistant glioblastoma. The gene discussed is ATR; the disease is neoplasm.